Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00664209 · ClinicalTrials.gov registry record · Phase 3
Treating H. Pylori in Parkinson's Patients With Motor Fluctuations
A Phase 3 study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- Phase 3
- Development phase
- 64
- Enrollment target
NCT00664209 is a Phase 3 study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 64 participants.
The verdict
NCT00664209, a Phase 3 study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether treatment of H. pylori (an infection of the stomach) improves treatment effectiveness in patients with Parkinson's disease and motor fluctuations.
Interventions
- DRUG placebo
- DRUG clartihromycin, amoxicillin, and omeprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2008-01 |
| Est. Completion | 2012-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00664209
The ClinicalTrials.gov registry entry for NCT00664209 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00664209 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00664209 about?
NCT00664209 is a clinical study titled "Treating H. Pylori in Parkinson's Patients With Motor Fluctuations". The purpose of this study is to determine whether treatment of H. pylori (an infection of the stomach) improves treatment effectiveness in patients with Parkinson's disease and motor fluctuations.
What is the current status of trial NCT00664209?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 64 participants. The study started on 2008-01. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00664209?
The interventions under investigation include: placebo (DRUG), clartihromycin, amoxicillin, and omeprazole (DRUG).
Who is sponsoring clinical trial NCT00664209?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.